Post-earnings recap
Reported
Mon, Aug 7, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report shows a positive surprise in EPS, which likely contributed to the stock's increase of 2.91%. The absence of revenue data leaves some uncertainty, but management's comments suggest they are focused on improving operations. Investors may view the EPS beat as a sign of resilience in the company's financial performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.33 | N/A | +1.11% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their commitment to enhancing operational efficiencies.
Management expressed satisfaction with the EPS performance despite the lack of revenue data.
The team highlighted ongoing efforts to improve operational efficiency.